Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Chandrakanthi Choornam in Oligospermia
NCT02234206Phase 2Completed
- Sponsor
- Tamil Nadu Dr. M.G.R. Medical University
- Start
- Dec 2012
- Primary completion
- Apr 2014
- Modality
- HM (Herbal Medicine)
- Countries
- 1
01
Overview
Phase 2, open-label, single-arm trial of Chandrakanthi Choornam in oligospermia, sponsored by Tamil Nadu Dr. M.G.R. Medical University. Primary endpoints: Sperm concentration per milliliter of seminal fluid at 90 days, Proportion of Sperm motility at 90 days and 1 more. Started Dec 2012; status: completed.
02
Drugs
Chandrakanthi Choornam
03
Conditions
oligospermia
Beyond the preview
Go deeper on NCT02234206.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02234206.